Manulife (Manufacturers Life Insurance)
KRYS icon

Manulife (Manufacturers Life Insurance)’s Krystal Biotech KRYS Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.32M Sell
36,069
-4,560
-11% -$1.21M 0.01% 878
2025
Q4 		$10.1M Buy
40,629
+6,174
+18% +$1.3M 0.01% 867
2025
Q3 		$6.08M Buy
34,455
+9,775
+40% +$1.46M 0.01% 1097
2025
Q2 		$3.39M Sell
24,680
-7,686
-24% -$1.13M ﹤0.01% 1316
2025
Q1 		$5.84M Sell
32,366
-2,840
-8% -$478K 0.01% 1103
2024
Q4 		$5.52M Buy
35,206
+3,981
+13% +$706K ﹤0.01% 1156
2024
Q3 		$5.68M Sell
31,225
-9,790
-24% -$1.89M 0.01% 1158
2024
Q2 		$7.53M Sell
41,015
-283
-0.7% -$47.5K 0.01% 955
2024
Q1 		$7.35M Buy
41,298
+12,048
+41% +$1.67M 0.01% 1005
2023
Q4 		$3.63M Buy
29,250
+8,813
+43% +$977K ﹤0.01% 1294
2023
Q3 		$2.37M Sell
20,437
-1,192
-6% -$145K ﹤0.01% 1384
2023
Q2 		$2.54M Buy
21,629
+13,108
+154% +$1.34M ﹤0.01% 1338
2023
Q1 		$682K Buy
8,521
+36
+0.4% +$2.83K ﹤0.01% 1816
2022
Q4 		$672K Buy
8,485
+150
+2% +$11.1K ﹤0.01% 1814
2022
Q3 		$581K Sell
8,335
-187
-2% -$13.5K ﹤0.01% 1880
2022
Q2 		$560K Buy
8,522
+396
+5% +$24.6K ﹤0.01% 1977
2022
Q1 		$541K Sell
8,126
-1,201
-13% -$75K ﹤0.01% 2158
2021
Q4 		$652 Sell
9,327
-210
-2% -$12.2K ﹤0.01% 2091
2021
Q3 		$498K Sell
9,537
-775
-8% -$45.9K ﹤0.01% 2286
2021
Q2 		$701K Buy
10,312
+1,595
+18% +$111K ﹤0.01% 2200
2021
Q1 		$672K Buy
8,717
+330
+4% +$24K ﹤0.01% 2111
2020
Q4 		$503K Buy
8,387
+604
+8% +$30.2K ﹤0.01% 2190
2020
Q3 		$335K Buy
7,783
+465
+6% +$20.2K ﹤0.01% 2219
2020
Q2 		$302K Buy
7,318
+449
+7% +$21.6K ﹤0.01% 2250
2020
Q1 		$297K Buy
6,869
+415
+6% +$21.7K ﹤0.01% 2100
2019
Q4 		$357K Buy
6,454
+83
+1% +$4.07K ﹤0.01% 2235
2019
Q3 		$226K Buy
6,371
+690
+12% +$30.8K ﹤0.01% 2503
2019
Q2 		$229K Buy
+5,681
New +$186K ﹤0.01% 2553

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s KRYS Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its Krystal Biotech (KRYS) stake by 11% in Q1 2026, selling an estimated $1.21M and leaving 36,069 shares worth $9.32M. The position accounts for 0.01% of the portfolio, ranked #878.

Manulife (Manufacturers Life Insurance) first reported a position in KRYS in Q2 2019 and has held it in 28 quarters since. The position peaked at $10.1M in Q4 2025. 367 funds tracked by Wall St. Rank hold KRYS as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 36,069 shares of Krystal Biotech worth $9.32M as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) sold 4,560 Krystal Biotech shares in Q1 2026, an estimated $1.21M.
  • Krystal Biotech made up 0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #878 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Krystal Biotech in Q2 2019 and has held it in 28 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Krystal Biotech position peaked at $10.1M in Q4 2025.
  • 367 funds tracked by Wall St. Rank held Krystal Biotech as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.